Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Cleantech, Live, Netscientific, Ondo,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Cleantech, Live, Netscientific, Ondo,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Ascent, Block, Corcel, Emmerson,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Abingdon, Empire, Jersey,
Leeds, UK, 15 February 2023 – 4D pharma plc (the “Company”) (AIM: DDDD, NASDAQ: LBPS) , a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Brickability, Bidstack, Cornerstone,
Nanoco Group (NANO), a specialist in the development and manufacture of cadmium-free quantum dots, announced the final agreements have been signed to settle the litigation with Samsung on a no
4D pharma Announces Updated Results from the Renal Cell Carcinoma Cohort of the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® (pembrolizumab)
Tap Global Group (AQSE: TAP), the regulated crypto app, announced the admission of its shares to trading on the Access Segment of the AQSE Growth Market, having raised gross proceeds
Nanoco Group (NANO), a specialist in the development and manufacture of cadmium-free quantum dots, announced that a term sheet for a no fault settlement of the current litigation has been
It would appear that it is take two as far as Hydrogen Utopia International (HUI)’s move to the standard list of the LSE. The company specialising in turning waste plastic
Leeds, UK – December 30, 2022 – 4D pharma plc (AIM: DDDD)Â (in administration), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived